Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person ERBB2 G778_P780dup mutant trans-autophosphorylates in the pr...

Class:IdSummation:9650903
_displayNameERBB2 G778_P780dup mutant trans-autophosphorylates in the pr...
_timestamp2023-03-18 14:35:32
created[InstanceEdit:9650905] Orlic-Milacic, Marija, 2019-06-24
modified[InstanceEdit:9831085] Orlic-Milacic, Marija, 2023-03-18
textERBB2 G778_P780dup mutant trans-autophosphorylates in the presence of EGFR, implying heterodimerization with EGFR (Bose et al. 2013, Suzawa et al. 2016, Ogoshi et al. 2018). Heterodimerizaiton and trans-autophosphorylation of ERBB2 G778_P780dup in the presence of ERBB3 or ERBB4 has not been examined. ERBB3 and ERBB4 are annotated as candidate heterodimerization partners.
[Change default viewing format]
No pathways have been reviewed or authored by ERBB2 G778_P780dup mutant trans-autophosphorylates in the pr... (9650903)